These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 7521445)
61. Differential effects of all-trans-retinoic acid, docosahexaenoic acid, and hexadecylphosphocholine on cisplatin-induced cytotoxicity and apoptosis in a cisplantin-sensitive and resistant human embryonal carcinoma cell line. Timmer-Bosscha H; de Vries EG; Meijer C; Oosterhuis JW; Mulder NH Cancer Chemother Pharmacol; 1998; 41(6):469-76. PubMed ID: 9554591 [TBL] [Abstract][Full Text] [Related]
62. MyD88 is an essential component of retinoic acid-induced differentiation in human pluripotent embryonal carcinoma cells. Sulaiman G; Cooke A; Ffrench B; Gasch C; Abdullai OA; O'Connor K; Elbaruni S; Blackshields G; Spillane C; Keegan H; McEneaney V; Knittel R; Rogers A; Jeffery IB; Doyle B; Bates M; d'Adhemar C; Lee MY; Campbell EL; Moynagh PN; Higgins DG; O'Toole S; O'Neill L; O'Leary JJ; Gallagher MF Cell Death Differ; 2017 Nov; 24(11):1975-1986. PubMed ID: 28885616 [TBL] [Abstract][Full Text] [Related]
63. Heterogeneous responses of human colon carcinomas to hexamethylene bisacetamide. Schroy PC; Carnright K; Winawer SJ; Friedman EA Cancer Res; 1988 Oct; 48(19):5487-94. PubMed ID: 2458179 [TBL] [Abstract][Full Text] [Related]
65. Transcriptional program of bone morphogenetic protein-2-induced epithelial and smooth muscle differentiation of pluripotent human embryonal carcinoma cells. Chadalavada RS; Houldsworth J; Olshen AB; Bosl GJ; Studer L; Chaganti RS Funct Integr Genomics; 2005 Apr; 5(2):59-69. PubMed ID: 15690164 [TBL] [Abstract][Full Text] [Related]
66. [Fundamental studies on differentiation inducers using a human embryonal carcinoma model]. Yamazawa K; Sekiya S; Kimura H; Shirasawa H; Kawata M; Takamizawa H Nihon Sanka Fujinka Gakkai Zasshi; 1991 Oct; 43(10):1303-9. PubMed ID: 1955781 [TBL] [Abstract][Full Text] [Related]
67. Proteome analysis of the effects of all-trans retinoic acid on human germ cell tumor cell lines. Honecker F; Rohlfing T; Harder S; Braig M; Gillis AJ; Glaesener S; Barett C; Bokemeyer C; Buck F; Brümmendorf TH; Looijenga LH; Balabanov S J Proteomics; 2014 Jan; 96():300-13. PubMed ID: 24269351 [TBL] [Abstract][Full Text] [Related]
68. Changes in protein synthesis during differentiation of embryonal carcinoma cells, and a comparison with embryo cells. Lovell-Badge RH; Evans MJ J Embryol Exp Morphol; 1980 Oct; 59():187-206. PubMed ID: 7217869 [TBL] [Abstract][Full Text] [Related]
69. Conversion of malignant murine embryonal carcinomas to benign teratomas by chemical induction of differentiation in vivo. Speers WC Cancer Res; 1982 May; 42(5):1843-9. PubMed ID: 6279284 [TBL] [Abstract][Full Text] [Related]
70. [Changes in various differentiation-related markers after differentiation induction of a pluripotent human embryonal carcinoma (EC) cell line by hexamethylene bisacetamide]. Kimura H; Sekiya S; Kawata M; Takamizawa H Nihon Sanka Fujinka Gakkai Zasshi; 1991 Nov; 43(11):1477-83. PubMed ID: 1682397 [TBL] [Abstract][Full Text] [Related]
71. Transcriptional profiling of neuronal differentiation by human embryonal carcinoma stem cells in vitro. Przyborski SA; Smith S; Wood A Stem Cells; 2003; 21(4):459-71. PubMed ID: 12832699 [TBL] [Abstract][Full Text] [Related]
75. Inhibitory control of neural differentiation in mammalian cells. Hoodless PA; Hemmati-Brivanlou A Dev Genes Evol; 1997 May; 207(1):19-28. PubMed ID: 20607477 [TBL] [Abstract][Full Text] [Related]
76. Osteogenic protein-2. A new member of the transforming growth factor-beta superfamily expressed early in embryogenesis. Ozkaynak E; Schnegelsberg PN; Jin DF; Clifford GM; Warren FD; Drier EA; Oppermann H J Biol Chem; 1992 Dec; 267(35):25220-7. PubMed ID: 1460021 [TBL] [Abstract][Full Text] [Related]
77. Bone morphogenetic proteins and retinoic acid induce human endogenous retrovirus HERV-K expression in NT2D1 human embryonal carcinoma cells. Caricasole A; Ward-van Oostwaard D; Mummery C; van den Eijnden-van Raaij A Dev Growth Differ; 2000 Aug; 42(4):407-11. PubMed ID: 10969740 [TBL] [Abstract][Full Text] [Related]
78. Expression of Wnt and Notch pathway genes in a pluripotent human embryonal carcinoma cell line and embryonic stem cell. Walsh J; Andrews PW APMIS; 2003 Jan; 111(1):197-210; discussion 210-1. PubMed ID: 12760378 [TBL] [Abstract][Full Text] [Related]
79. Chemically induced bidirectional differentiation of embryonal carcinoma cells in vitro. Speers WC; Birdwell CR; Dixon FJ Am J Pathol; 1979 Dec; 97(3):563-84. PubMed ID: 507191 [TBL] [Abstract][Full Text] [Related]
80. Multidrug transport in human glioblastoma cells is inhibited by transforming growth factors type beta 1, beta 2, and beta 1.2. Schluesener HJ J Neurosci Res; 1991 Feb; 28(2):310-4. PubMed ID: 2033654 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]